These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38319556)

  • 1. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
    Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M
    Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults.
    Jongo SA; Urbano V; Church LWP; Olotu A; Manock SR; Schindler T; Mtoro A; Kc N; Hamad A; Nyakarungu E; Mpina M; Deal A; Bijeri JR; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema GN; Owono SN; Rivas MR; Chemba M; Kassim KR; James ER; Stabler TC; Abebe Y; Saverino E; Sax J; Hosch S; Tumbo AM; Gondwe L; Segura JL; Falla CC; Phiri WP; Hergott DEB; García GA; Schwabe C; Maas CD; Murshedkar T; Billingsley PF; Tanner M; Ayekaba MO; Sim BKL; Daubenberger C; Richie TL; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2021 Jan; 104(1):283-293. PubMed ID: 33205741
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
    Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
    Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
    Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.
    Coulibaly D; Kone AK; Traore K; Niangaly A; Kouriba B; Arama C; Zeguime A; Dolo A; Lyke KE; Plowe CV; Abebe Y; Potter GE; Kennedy JK; Galbiati SM; Nomicos E; Deye GA; Richie TL; James ER; Kc N; Sim BKL; Hoffman SL; Doumbo OK; Thera MA; Laurens MB;
    EClinicalMedicine; 2022 Oct; 52():101579. PubMed ID: 35928033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.
    Oneko M; Steinhardt LC; Yego R; Wiegand RE; Swanson PA; Kc N; Akach D; Sang T; Gutman JR; Nzuu EL; Dungani A; Kim Lee Sim B; Oloo PN; Otieno K; Bii DK; Billingsley PF; James ER; Kariuki S; Samuels AM; Jongo S; Chebore W; Abdulla S; Daubenberger C; Mpina M; Styers D; Potter GE; Abarbanell G; Richie TL; Hoffman SL; Seder RA
    Nat Med; 2021 Sep; 27(9):1636-1645. PubMed ID: 34518679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
    Sulyok Z; Fendel R; Eder B; Lorenz FR; Kc N; Karnahl M; Lalremruata A; Nguyen TT; Held J; Adjadi FAC; Klockenbring T; Flügge J; Woldearegai TG; Lamsfus Calle C; Ibáñez J; Rodi M; Egger-Adam D; Kreidenweiss A; Köhler C; Esen M; Sulyok M; Manoj A; Richie TL; Sim BKL; Hoffman SL; Mordmüller B; Kremsner PG
    Nat Commun; 2021 May; 12(1):2518. PubMed ID: 33947856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Differential Antibody and T-Cell Responses to the
    Jongo SA; Church LWP; Mtoro AT; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Gondwe L; Studer F; Fink M; Cosi G; El-Khorazaty J; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2019 Jun; 100(6):1433-1444. PubMed ID: 30994090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
    Murphy SC; Deye GA; Sim BKL; Galbiati S; Kennedy JK; Cohen KW; Chakravarty S; Kc N; Abebe Y; James ER; Kublin JG; Hoffman SL; Richie TL; Jackson LA
    PLoS Pathog; 2021 May; 17(5):e1009594. PubMed ID: 34048504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporozoite immunization: innovative translational science to support the fight against malaria.
    Richie TL; Church LWP; Murshedkar T; Billingsley PF; James ER; Chen MC; Abebe Y; Natasha Kc ; Chakravarty S; Dolberg D; Healy SA; Diawara H; Sissoko MS; Sagara I; Cook DM; Epstein JE; Mordmüller B; Kapulu M; Kreidenweiss A; Franke-Fayard B; Agnandji ST; López Mikue MA; McCall MBB; Steinhardt L; Oneko M; Olotu A; Vaughan AM; Kublin JG; Murphy SC; Jongo S; Tanner M; Sirima SB; Laurens MB; Daubenberger C; Silva JC; Lyke KE; Janse CJ; Roestenberg M; Sauerwein RW; Abdulla S; Dicko A; Kappe SHI; Sim BKL; Duffy PE; Kremsner PG; Hoffman SL
    Expert Rev Vaccines; 2023; 22(1):964-1007. PubMed ID: 37571809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine.
    Senkpeil L; Bhardwaj J; Little MR; Holla P; Upadhye A; Fusco EM; Swanson PA; Wiegand RE; Macklin MD; Bi K; Flynn BJ; Yamamoto A; Gaskin EL; Sather DN; Oblak AL; Simpson E; Gao H; Haining WN; Yates KB; Liu X; Murshedkar T; Richie TL; Sim BKL; Otieno K; Kariuki S; Xuei X; Liu Y; Polidoro RB; Hoffman SL; Oneko M; Steinhardt LC; Schmidt NW; Seder RA; Tran TM
    JCI Insight; 2024 Apr; 9(11):. PubMed ID: 38687615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men.
    Olotu A; Urbano V; Hamad A; Eka M; Chemba M; Nyakarungu E; Raso J; Eburi E; Mandumbi DO; Hergott D; Maas CD; Ayekaba MO; Milang DN; Rivas MR; Schindler T; Embon OM; Ruben AJ; Saverino E; Abebe Y; Kc N; James ER; Murshedkar T; Manoj A; Chakravarty S; Li M; Adams M; Schwabe C; Segura JL; Daubenberger C; Tanner M; Richie TL; Billingsley PF; Lee Sim BK; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Jan; 98(1):308-318. PubMed ID: 29141739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Omaswa F; Zaidi I; Gabriel EE; Kamate B; Samake Y; Guindo MA; Dolo A; Niangaly A; Niaré K; Zeguime A; Sissoko K; Diallo H; Thera I; Ding K; Fay MP; O'Connell EM; Nutman TB; Wong-Madden S; Murshedkar T; Ruben AJ; Li M; Abebe Y; Manoj A; Gunasekera A; Chakravarty S; Sim BKL; Billingsley PF; James ER; Walther M; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2017 May; 17(5):498-509. PubMed ID: 28216244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.
    Mordmüller B; Surat G; Lagler H; Chakravarty S; Ishizuka AS; Lalremruata A; Gmeiner M; Campo JJ; Esen M; Ruben AJ; Held J; Calle CL; Mengue JB; Gebru T; Ibáñez J; Sulyok M; James ER; Billingsley PF; Natasha KC; Manoj A; Murshedkar T; Gunasekera A; Eappen AG; Li T; Stafford RE; Li M; Felgner PL; Seder RA; Richie TL; Sim BK; Hoffman SL; Kremsner PG
    Nature; 2017 Feb; 542(7642):445-449. PubMed ID: 28199305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.
    Roestenberg M; Walk J; van der Boor SC; Langenberg MCC; Hoogerwerf MA; Janse JJ; Manurung M; Yap XZ; García AF; Koopman JPR; Meij P; Wessels E; Teelen K; van Waardenburg YM; van de Vegte-Bolmer M; van Gemert GJ; Visser LG; van der Ven AJAM; de Mast Q; Natasha KC; Abebe Y; Murshedkar T; Billingsley PF; Richie TL; Sim BKL; Janse CJ; Hoffman SL; Khan SM; Sauerwein RW
    Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Diawara H; Healy SA; Mwakingwe-Omari A; Issiaka D; Diallo A; Traore S; Soumbounou IH; Gaoussou S; Zaidi I; Mahamar A; Attaher O; Fried M; Wylie BJ; Mohan R; Doan V; Doritchamou JYA; Dolo A; Morrison RD; Wang J; Hu Z; Rausch KM; Zeguime A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Dicko A; Duffy PE;
    Lancet Infect Dis; 2024 Dec; 24(12):1366-1382. PubMed ID: 39153490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity.
    Mwakingwe-Omari A; Healy SA; Lane J; Cook DM; Kalhori S; Wyatt C; Kolluri A; Marte-Salcedo O; Imeru A; Nason M; Ding LK; Decederfelt H; Duan J; Neal J; Raiten J; Lee G; Hume JCC; Jeon JE; Ikpeama I; Kc N; Chakravarty S; Murshedkar T; Church LWP; Manoj A; Gunasekera A; Anderson C; Murphy SC; March S; Bhatia SN; James ER; Billingsley PF; Sim BKL; Richie TL; Zaidi I; Hoffman SL; Duffy PE
    Nature; 2021 Jul; 595(7866):289-294. PubMed ID: 34194041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.